Ambey Laboratories Limited IPO
Price
₹65 - ₹68
Lot
10
Subs.
N/A
Expected Listing Earning

Exp. Premium(GMP):
22.00(32.35%)
IPO Details

Open Date: 04-Jul-2024
Close Date: 08-Jul-2024
Allotment Date: 09-Jul-2024
Listing Date: 11-Jul-2024
Listing Price: N/A
Face Value: ₹10 Per Equity Share
Issue Price: ₹65-68 Per Equity Share
Issue Size: Total Issue Size 6,570,000 shares (aggregating up to ₹44.68 Cr) : Fresh Issue 6,258,000 shares (aggregating up to ₹42.55 Cr) : Offer for Sale 312,000 shares of ₹10 (aggregating up to ₹2.12 Cr)
Market Lot (Min Amount): Retail - ₹136,000 : HNI - ₹272,000
Valuations

Earning Per Share(EPS)₹2.44/-
P/E Ratio27.81
RoNW20.80%
Net Asset Value (NAV) - Post Issue:₹13.32/-
Company Financials (in Crore)

 Total AssetsTotal RevenueProfit After Tax
31 Jan,20248,620.8410,043.69607.73
31 Mar,20235,761.8510,743.47456.93
31 Mar,20225,592.948,511.19357.47
31 Mar,20214,461.808,241.541,033.67
Promoter(s)

Pre Issue Share Holding94.97%
Post Issue Share HoldingN/A%
Company Promoter(s)
1. Archit Gupta
2. Arpit Gupta
3. Sarina Gupta
4. Rishita Gupta
Issue Objective(s)

The company intends to utilize the Net Proceeds for the following objects:

  • To meet Working Capital Requirements
  • General corporate purposes
  • Issue related expenses
About Company

Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.

The company manufactures and supplies 2,4-D base chemicals.

The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.

The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:

  • 2,4-D Acid 98% TC
  • 2,4-D Sodium 95% SP
  • 2,4-D Amine 866 | 720 | 480g/l SL
  • 2,4-D Ethyl Hexyl Ester 96% TC
  • 2,4-D Ethyl Ester 96% TC
  • Chlorpyriphos 97%TC / 20%EC / 50%EC
  • Thiamethoxam 96%TC / 25%WG / 75%SG
  • Pretilachlor 95%TC / 50%EC / 37%EW
  • Metribuzin 97%TC / 70%WS
  • Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC
  • Metalaxyl 98%TC / 35%WS

 As of October 31, 2023 the company employs 220 people in various departments.

Disclaimer

No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. 

Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.

If you are agree with app tems and condition to use the app. 

Thank you.